The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...

Glucotrack today announced the results from the first-in-human clinical study of its long-term continuous blood glucose ...

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

The components of the Eversense 365 CGM. [Image courtesy of Senseonics/Ascensia] Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

“Inhaled insulin can quickly get to the carbohydrates that are in the bloodstream, get them into the cells and out of the ...

(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

The system — similar to continuous glucose monitoring (CGM) uses a new method of continuously sensing specific chemistry ...

LifePlus announced the clinical validation of its non-invasive and cuffless wearable for continuous glucose and blood ...

For many, a partnership between Abbott and Medtronic, two medtech giants and frequent competitors, would have seemed unlikely ...